The first single-pill combination of a beta-blocker and ACE inhibitor became available in 2016 in the form of bisoprolol/perindopril (Cosyrel®) and is indicated in arterial hypertension, stable CAD, and/or heart failure. This evidence concerns the gene ACE and heart failure.